High Court Dismisses Sun Pharma Writ Petition

Mumbai: The Bombay High Court last week dismissed a writ petition filed by Sun Pharma while directing it to pay pending salary and expenses of the medical and sales representatives that had been withheld for the last few months. Sun Pharma had issued transfer notices to roughly 50 of its medical representatives as part of its integration with Ranbaxy. The staffers had opposed those transfers, triggering the conflict. The court also rejected a writ filed by the FMRAI seeking modifications to an earlier order of an Industrial Court. The court directed the group of medical representatives to align with a new system of reporting structure that was proposed by the company as part of its marketing overhaul.

Subscribe ETHealthworld Newsletter

Lyrica, known generically as pregabalin, was originally developed for epilepsy but further research showed it could also help patients suffering from neuropathic pain, which soon became its main market.

With this acquisition, Nephroplus will further strengthen its servicing capacity as the dominant dialysis centre network and will have a presence in 18 states of India with 176 centers across 97 cities.